Abstract #2117

Whole Body Diffusion Weighted Imaging/ADC Mapping and MR Spectroscopy for Detection and Monitoring of Metastatic Cancer at 3T:Preliminary Results

Michael A. Jacobs^1,2, Li Pan³, Katarzyna Macura⁴, Ronald Ouwekerk⁴, Antonio C. Wolff², Vered Stearns², Ihab Kamel⁴, Nouha Salibi³, Wilhelm Horger⁵, David Bluemke⁴, Christine Lorenz³

¹The Russell H. Morgan Department of Radiology and Radiological Science , The Johns Hopkins University School of Medicine, Baltimore , MD , USA; ²Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; ³Siemens Corporate Research, Inc., Baltimore, MD, USA; ⁴The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; ⁵Siemens AG Healthcare Sector, Erlangen, Germany

The ability to diagnose metastatic disease without radiation would be an advancement in the initial work-up of cancer[1]. The purpose of this study was to investigate the potential use of a novel whole body diffusion weighted imaging (WB-DWI) method coupled magnetic resonance spectroscopy (MRS) for the detection and monitoring of metastatic disease in patients and transition to 3T.